NextGen Vaccines Holding ApS: Financial statements 2024
CVR: 38706721
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
NextGen Vaccines Holding ApS (CVR 38706721) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -32,686 and a net result of DKK 28,029,025 compared with DKK -67,580 the year before. Equity in the 2024 report amounted to DKK 281,101. The solvency ratio was 38%.
- Gross Profit
- DKK -32,686
- Profit/Loss
- DKK 28,029,025
- Equity
- DKK 281,101
- Total Assets
- DKK 740,039
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -33K | 28M | 281K | - |
| 2023 | - | -67K | -68K | 202K | - |
| 2022 | - | -36K | -51K | 270K | - |
| 2021 | - | -330K | 347K | 321K | - |
| 2020 | - | -335K | -330K | -26K | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
NextGen Vaccines Holding ApS has published its annual report for 2023. Gross profit came to DKK -67,041, and the net result was DKK -67,580.
About NextGen Vaccines Holding ApS
NextGen Vaccines Holding ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Adam Frederik Sander Bertelsen. The board consists of Morten Agertoug Nielsen (chair), Adam Frederik Sander Bertelsen, Ali El-Salanti and Jacob Hjulmand. The company's owners include Ali El-Salanti, Morten Agertoug Nielsen and Adam Frederik Sander Bertelsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -29,096 and a net result of DKK -51,555 compared with DKK 28,029,025 the year before. Equity in the 2025 report amounted to DKK 229,546.